Dr. Deepak Sarin (Surgical Oncologist)

About Dr. Deepak Sarin

• Dr. Deepak Sarin is a head and neck onco-surgeon with 20+ years of experience.
• He has won the Chandler Society Award (USA), Mukut Sahariya Award, and Kamani Charity Book Prize (Gold Medal in MS).
• He has established the head and neck surgery department in Sir Ganga Ram Hospital in 2005, Artemis Health Institute in 2007, and Medanta in 2011.
• Dr. Sarin has completed MBBS, MS with Gold Medal, DNB, and Fellowship.
• He holds expertise in Throat Cancer, Oral Cancer, Thyroid surgery, Parathyroid surgery, Tracheal reconstruction, Parotid surgery, and Laser and Robotic.

Special Interest

Oral Cancer Surgery, Thyroid and Parathyroid Surgery, Complex Reconstruction of head and neck defects, Robotic and Laser Surgery

List Of Treatments

• Chemotherapy
• Adrenal Cancer Treatment
• Anal Cancer Treatment
• Aplastic Anemia
• Bile Duct Cancer Treatment
• Bladder Cancer Treatment
• Bone Cancer Treatment
• Brain CNS Tumor Treatment - Adults
• Brain CNS Tumors Treatment - Children
• Breast Cancer-Surgical
• Breast Cancer Treatment for Men
• Cancer in Children
• Carcinoma of Unknown Primary (CUP) Treatment
• Castleman Disease Treatment
• Cervical Cancer Treatment
• Endometrial Cancer Treatment
• Esophagus Cancer Treatment
• Ewing Family of Tumors Treatment
• Eye Cancer Treatment
• Gallbladder Cancer Treatment
• Carcinoid Tumors Treatment
• Gastrointestinal Stromal Tumor GIST Treatment
• Gestational Trophoblastic Disease (GTD) Treatment
• Hodgkin Disease Treatment
• Kaposi Sarcoma Treatment
• Kidney Cancer Treatment
• Laryngeal and Hypopharyngeal Cancer Treatment
• Acute Lymphocytic Leukemia - ALL in Adults
• Leukemia - Acute Myeloid AML
• Chronic Lymphocytic Leukemia - CLL
• Chronic Myeloid Leukemia- CML
• Chronic Myelomonocytic Leukemia - CMML
• Leukemia in Children
• Liver Cancer
• Lung Cancer Treatment
• Non-Small Cell Lung Cancer (NSCLC) Treatment
• Small-cell Carcinoma Treatment
• Lung Carcinoid Tumor Treatment
• Skin Lymphoma Treatment
• Malignant Mesothelioma Treatment
• Multiple Myeloma Treatment
• Myelodysplastic Syndrome (MDS) Treatment - Preleukemia
• Nasal Cavity and Paranasal Sinus Cancer Treatment
• Nasopharyngeal Cancer Treatment
• Neuroblastoma
• Non-Hodgkin Lymphoma (NHL) Treatment
• Non-Hodgkin Lymphoma In Children
• Oral Cavity and Oropharyngeal Cancer
• Osteosarcoma (OS) Treatment
• Ovarian Cancer Surgery
• Pancreatic Cancer
• Penile Cancer Treatment
• Prostate Cancer-Surgical
• Retinoblastoma (RB) Treatment
• Rhabdomyosarcoma (RMS) Treatment
• Salivary Gland Cancer
• Soft Tissue Sarcoma Treatment
• Skin Cancer
• Basal Cell and Squamous Cell Carcinoma
• Skin Cancer - Melanoma
• Small Intestine Cancer Treatment
• Stomach Cancer Treatment
• Testicular Cancer Treatment
• Thymoma and Thymic Carcinoma Treatment
• Thyroid Cancer Treatment
• Uterine Sarcoma
• Vaginal Cancer Treatment
• Vulvar Cancer Treatment
• Waldenstrom Macroglobulinemia
• Wilms Tumor (Nephroblastoma)
• Breast Biopsy
• Autologous Stem Cell Transplant for Lymphoma
• Allogeneic Bone Marrow Transplant
• Pediatric Bone Marrow Transplant
• Thalassemia Treatment
• Oral Cancer - Surgical
• Breast Cancer
• Leukemia Treatment
• Hairy Cell Leukemia - HCL
• Fallopian Tube Cancer
• Ovarian Germ Cell Tumor
• Ovarian Primary Peritoneal Cancer
• Medullary Carcinoma
• Papillary Thyroid Cancer Treatment
• Bone Marrow Cancer
• Ovarian Sex Cord Stromal Tumor
• Invasive Lobular Carcinoma
• Colon Cancer Treatment
• Cancer Treatment

Work Profile

Director, Medanta - The Medicity, Gurgaon

Head of Department, Artemis Hospital, Gurgaon

Consultant, Sir Ganga Ram Hospital, New Delhi

Education

• Fellowship, 2005, University of MIAMI

• DNB, 2001, National Board of Examination

• MS, 1997, AIIMS, New Delhi

• MBBS, 1994, All India Institute of Medical Sciences, New Delhi

Awards

1. Chandler Society Award (USA), 2005 2. Mukut Sahariya Award, 1997 3. Kamani Charity Book Prize (Gold Medal in MS), 1997

Paper Published

• Role of laminin – 10 in spread of Head & Neck Squamous Cell Cancer
• Role of PET scan in detecting recurrence following curative treatment for Head & Neck Cancer. Comparison with conventional imaging
• Histopathogic markers for aggressiveness in Head & Neck Cancer. A review on the prognostic and therapeutic implications